African Society of Human Genetics Conference

非洲人类遗传学会会议

基本信息

项目摘要

The African Society of Human Genetics (AfSHG) was formed in 2003 to ensure that Africa is not left out of the genomic revolution. To meet this objective, the society has since then provided a forum for scientists to interact and exchange information in the field of genetics and genomics. This has been successfully achieved through earlier meetings held in Accra, Ghana - 2003, Washington DC - 2004, Johannesburg, south Africa -2005, Addis Abba, Ethiopia - 2006, Cairo, Egypt - 2007, Yaounde, Cameroon - 2009, Cape Town. South Africa - 2011 , Accra - 2013 and Dakar, Senegal - 2016. Scientists and physicians from over 21 African countries, several European countries, Asia, and the Americas attended these meetings. These meetings have Advanced the fundamental goals of the society including education, networking, capacity building, and research development. In addition, this Society through previous meetings has been instrumental in the development of the African Genome Project. The theme of the upcoming meeting will be "Human genetics and genomics in Africa: Challenges for both rare and common genetic disorders". The current proposal is requesting funding for this meeting, one to be held in Rwanda in in 2018 and a third to be held in 2019 in an African host country to be determined. We recognize that as the genomic revolution develops it is important that equity in genetic research and translation into clinical practice needs to be seriously addressed. Previous meetings have dealt with some of these issues, and the results of these meetings have been incorporated into the global genomics enterprise to the extent that African studies, although still relatively rare, are gaining prominence in the genetics literature. The theme of the upcoming meeting has been chosen to specially incorporate several issues in modem genomics research, including the use of Next Generation Sequencing to detect all variants, the role of stem cell research in genetics research and the practical and ethical issues surrounding biobanking of samples in Africa. The Microbiome and Health , Human History and Population Genetics, Genomic Medicine, Networking/Resource Building and Developing Collaborations, and Bioethics and Benefit Sharing are themes that will be explored during the meeting. Invited speakers include Stylianos Antonarakis (Geneva), Raj Ramesar (Cape Town). Clement Adebomowo (Maryland), Moses Joloba (Uganda), Collen Masimirembwa (Harare, Zimbabwe). Chris Mathew (Johannesburg) and Charles Rotimi (NIH), several of whom have attended previous Meetings of the AfSHG. Finally, to better integrate the development of genetic research in Africa, the AfSHG meeting in Cairo will be held jointly with the National Society of Human Genetics of Egypt. This is a strategy that has been used successfully in previous meetings to engage existing African scientific organizations in genomics.
非洲人类遗传学会(AfSHG)成立于2003年,目的是确保非洲不会重蹈覆辙

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Scott Matthew Williams其他文献

Scott Matthew Williams的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Scott Matthew Williams', 18)}}的其他基金

International Congress of Human Genetics 2022
2022 年国际人类遗传学大会
  • 批准号:
    10391940
  • 财政年份:
    2022
  • 资助金额:
    $ 6万
  • 项目类别:
Primaquine metabolism and treatment of P. vivax in Madagascar
马达加斯加间日疟原虫的伯氨喹代谢和治疗
  • 批准号:
    10543818
  • 财政年份:
    2020
  • 资助金额:
    $ 6万
  • 项目类别:
Primaquine metabolism and treatment of P. vivax in Madagascar
马达加斯加间日疟原虫的伯氨喹代谢和治疗
  • 批准号:
    10323031
  • 财政年份:
    2020
  • 资助金额:
    $ 6万
  • 项目类别:
Primaquine metabolism and treatment of P. vivax in Madagascar
马达加斯加间日疟原虫的伯氨喹代谢和治疗
  • 批准号:
    10078592
  • 财政年份:
    2020
  • 资助金额:
    $ 6万
  • 项目类别:
African Society of Human Genetics Conference
非洲人类遗传学会会议
  • 批准号:
    9756438
  • 财政年份:
    2017
  • 资助金额:
    $ 6万
  • 项目类别:
African Society of Human Genetics Conference
非洲人类遗传学会会议
  • 批准号:
    9472021
  • 财政年份:
    2017
  • 资助金额:
    $ 6万
  • 项目类别:
African Society of Human Genetics Conference
非洲人类遗传学会会议
  • 批准号:
    8066837
  • 财政年份:
    2011
  • 资助金额:
    $ 6万
  • 项目类别:
Pilot Project 42
试点项目 42
  • 批准号:
    7486597
  • 财政年份:
    2007
  • 资助金额:
    $ 6万
  • 项目类别:
Genetic analysis of keloids
疤痕疙瘩的遗传分析
  • 批准号:
    6532222
  • 财政年份:
    2003
  • 资助金额:
    $ 6万
  • 项目类别:
Genetic analysis of keloids
疤痕疙瘩的遗传分析
  • 批准号:
    6804391
  • 财政年份:
    2003
  • 资助金额:
    $ 6万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 6万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 6万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 6万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 6万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 6万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 6万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 6万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了